Step 4: Buy Your Customized GLP-1 Solution After your consultation, you can purchase your preferred GLP-1 solution for your custom-tailored weight care program
Some users who do not respond adequately to semaglutide drops find better results with tirzepatide drops, and vice versa
"Mazdutide (IBI362), a GLP-1/glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple-ascending-dose phase 2 trial." EClinicalMedicine 59 (2023)
Semaglutide was originally designed to treat Type 2 diabetes, helping cases manage blood sugar situations effectively before its weight loss operations surfaced
On average, patients who respond well to Ozempic as a weight loss treatment will lose around 6% of their body weight within the first year of taking the medication, with those who continue taking it for at least 18 months being able to lose closer to 1015% of their body weight
PubMed CrossRef Mansur RB, Ahmed J, Cha DS, et al